Fiche publication
Date publication
octobre 1995
Journal
Naunyn-Schmiedeberg's archives of pharmacology
Auteurs
Membres identifiés du Cancéropôle Est :
Dr DAEFFLER Laurent
Tous les auteurs :
Lach E, Daeffler L, Waeldelé F, Gies JP
Lien Pubmed
Résumé
We have investigated the effects of a nitric oxide (NO) biosynthesis inhibitor N omega-nitro-L-arginine methyl ester (L-NAME) on the bombesin-evoked contraction of guinea pig parenchymal lung strips. The bombesin-induced contractions of lung strips were significantly increased after L-NAME (300 micro)) pre-treatment. The maximal response was increased (P < 0.01) by 37% after L-NAME treatment when compared with the control group. The pD2 value was not influenced by L-NAME pre-treatment. The enhancement of the bombesin-induced contraction caused by L-NAME was reversed by addition of an excess of the NO precursor L-arginine (600 microM) but not by the addition of its inactive enantiomer D-arginine (600 microM). Like L-NAME, methylene blue (1 microM), an agent that inhibits the soluble guanylyl cyclase activated by NO, significantly increased (P < 0.01) the maximal contraction induced by bombesin (183 +/- 16 mg) when compared with the control group (141 +/- 15 mg). When tested against other agonist-induced contractions, L-NAME did not change the responsiveness of parenchymal lung strips to bradykinin or carbachol but significantly increased lung contraction induced by histamine. NO synthesis inhibition resulted in a pronounced increase in the bombesin-induced contraction of guinea-pig lung strips. Our results suggest that bombesin contributes to NO synthesis and release which then acts to reduce the contraction of the lungstrip in response to bombesin.
Mots clés
Animals, Arginine, analogs & derivatives, Bombesin, pharmacology, Guinea Pigs, In Vitro Techniques, Lung, drug effects, Male, Muscle Contraction, drug effects, NG-Nitroarginine Methyl Ester, Nitric Oxide, physiology
Référence
Naunyn Schmiedebergs Arch. Pharmacol.. 1995 Oct;352(4):419-23
